Evidence map›Paper›PMID 31949645›Full record

ArticleInternational journal of clinical and experimental pathology2018

The clinicopathological features of metastatic tumors of the bladder: analysis of 25 cases.

Luhua Wang, Guoxin Song, Weiming Zhang, Zhihong Zhang

Abstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Luhua WangDepartment of Pathology, The First Affiliated Hospital of Nanjing Medical University Nanjing, P. R. China.
Guoxin SongDepartment of Pathology, The First Affiliated Hospital of Nanjing Medical University Nanjing, P. R. China.
Weiming ZhangDepartment of Pathology, The First Affiliated Hospital of Nanjing Medical University Nanjing, P. R. China.
Zhihong ZhangDepartment of Pathology, The First Affiliated Hospital of Nanjing Medical University Nanjing, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo introduce the histological features and immunohistochemical results of bladder metastatic tumors, with emphasis on the points of distinction from primary bladder tumors.

methodsA total of 25 cases were diagnosed as bladder metastatic tumors in the First Affiliated Hospital of Nanjing Medical University from January 1, 2009 to August 31, 2017. All of these were retrospectively analyzed, and immunohistochemical stainings were performed to confirm the diagnoses.

resultsThe most common primary sites in the 25 cases were the colon (24.0%), the prostate (24.0%), the stomach (16.0%), the cervix (12.0%), the kidneys (12.0%), the rectum (8.0%) and the breasts (4.0%). Most of the tumors in these areas reached the bladder by direct diffusion. The most common sites of tumor origin that metastasized to the bladder in the distance were the stomach (16.0% of all metastatic bladder tumors) and the breasts (4.0%). Histologically, 76% of the metastatic tumors were adenocarcinomas.

conclusionBladder metastases are uncommon, and distant metastases are rare. Metastatic tumors lack unique histological features, especially adenocarcinoma, which require differential diagnosis both clinically and histologically, hence knowledge of their medical history and clinical data are particularly important in their diagnosis.

Indexed as

Bladderdiagnosisdifferential diagnosisimmunohistochemistrymetastatic tumor

Identifiers

PMID31949645
PMCPMC6963057

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.